GLP-1 Weight Loss in Syracuse, NY: A High-Need Market With an Opaque Local Price and a Real Specialist Gap
Syracuse's obesity rate against Onondaga County and New York State, the NYRx weight-loss exclusion, a price-opacity finding inside city limits, and a re-designated low-income shortage area.
41.5% of Syracuse adults have obesity (crude prevalence, CDC PLACES 2025 release) 1, against Onondaga County's 36.9% 2 and New York State's 28.0% 3. The state figure comes from a different CDC survey methodology, BRFSS direct survey, than the city and county figures, which are PLACES small-area model estimates, so the 13.5-point gap is directional rather than a like-for-like comparison.
In a city of 146,091 with a median household income of $51,770 4, the local GLP-1 question is not whether specialists exist, because they do, but whether anyone will tell you a price.
Active HRSA-designated Low-Income Population Primary Care HPSA, 'LI-Syracuse RSA-52' (HPSA ID 1366668191), re-designated 03/26/2026, spanning 59 census tracts in Onondaga County: score 16/26, population-to-provider ratio 8,219:1 against a 3,000:1 goal, designation population 74,537 of whom 27.9% are below the poverty line. A parallel Low-Income Population Mental Health HPSA ('LI-City of Syracuse RSA 52', score 19) covers the same population. Two facility-based Designated HPSAs sit inside city limits: Syracuse Community Health Center Inc (FQHC, 819 S Salina St; PC score 18 / MH score 20, continuously designated since 2003) and Liberty Resources Inc (FQHC Look-Alike, 1045 James St; PC score 20 / MH score 16, designated 2023). A separate Medicaid-Eligible-Population geographic HPSA covering overlapping tracts was withdrawn 07/01/2026 — the Low-Income Population designation above is the one currently in force.7
Specialist access
SUNY Upstate Medical University runs a Joslin-Diabetes-Center-affiliated Division of Endocrinology, Diabetes, and Metabolism and a Bariatric and Metabolic Surgery Program accredited as a Comprehensive Center under MBSAQIP — genuine specialist depth for a market this size. That academic-referral pathway exists alongside, not instead of, the primary-care access gap documented above: it requires insurance and referral, not same-week cash-pay access, which is the gap a direct telehealth option fills.1011
Medicaid coverage note
New York's Medicaid pharmacy program (NYRx) categorically excludes 'drugs used for the treatment of anorexia, weight loss or weight gain' — confirmed verbatim in the primary eMedNY 'NYRx Pharmacy Policy Guidelines' (version 2026-2, March 2026), citing Social Security Act §1927(d)(2). This sweeps in Wegovy, Zepbound, and Saxenda when prescribed for chronic weight management. The same molecules (Ozempic, Mounjaro, Trulicity, Rybelsus, Victoza) remain covered under NYRx when prescribed for type 2 diabetes with standard prior authorization — this brand-name split is a reasonable inference from the indication-based exclusion, not an itemized statement in the primary document. Nationally, KFF found only 13 state Medicaid programs covered GLP-1s for obesity under fee-for-service as of January 2026; New York was not among them in any source checked.16
What NYRx excludes
New York's Medicaid pharmacy program, NYRx, categorically excludes drugs used for the treatment of anorexia, weight loss or weight gain, confirmed verbatim in the primary eMedNY NYRx Pharmacy Policy Guidelines (version 2026-2, March 2026), citing Social Security Act §1927(d)(2) 16. That sweeps in Wegovy, Zepbound, and Saxenda when prescribed for chronic weight management.
The same molecules, Ozempic, Mounjaro, Trulicity, Rybelsus, and Victoza, remain covered under NYRx when prescribed for type 2 diabetes with standard prior authorization; that brand-name split is a reasonable inference from the indication-based exclusion, not an itemized statement in the primary document 16. Nationally, KFF found only 13 state Medicaid programs covered GLP-1s for obesity under fee-for-service as of January 2026, and New York was not among them in any source checked 15.
What GLP-1 care costs in Syracuse today
This is a price-opacity finding, not a price table: zero verified in-city providers publish a GLP-1 price. Slim Weight Loss Clinic at 120 E Washington St downtown is the only address of all providers checked that the Census Bureau geocoder confirms sits inside true Syracuse city limits (GEOID 3673000), and its site publishes no semaglutide or tirzepatide price, routing visitors to a consultation-request form, confirmed by direct fetch with no dollar figure anywhere on the page (checked Aug 28, 2026) 149.
The two nearby clinics that do publish prices are outside the city line. Flawless Image Medical Aesthetics at 5805 Bridge St geocodes to the Village of East Syracuse, Town of DeWitt, and publishes GLP-1/GIP injectable pricing at $360/month cash or $385/month by card for months one through three, rising to $360 to $475/month thereafter depending on dose, with free consultations and labs and no contract; the page does not pair a specific semaglutide dose figure with that price, so it is a general GLP-1/GIP rate 12. Captivate IV Wellness & Beauty Bar at 4306 E Genesee St carries a Syracuse 13214 postal designation but returns no incorporated-place match in the Census geocoder, indicating unincorporated DeWitt, and publishes a bundled SLIM membership starting at $175/month covering provider check-ins, labs, body-composition scans, and infrared sauna rather than an itemized drug price 13.
Astra's price is national and flat: $68/month for semaglutide and $118/month for tirzepatide on 12-month plans, $816 and $1,416 per year, identical in every city.
Real specialists, and a shortage designation renewed in March 2026
SUNY Upstate Medical University runs a Joslin-Diabetes-Center-affiliated Division of Endocrinology, Diabetes, and Metabolism and a Bariatric and Metabolic Surgery Program accredited as a Comprehensive Center under MBSAQIP, genuine specialist depth for a market this size 1011. That academic-referral pathway exists alongside, not instead of, a documented primary-care access gap: it requires insurance and referral, not same-week cash-pay access.
HRSA's active Low-Income Population Primary Care HPSA, LI-Syracuse RSA-52 (HPSA ID 1366668191), was re-designated 03/26/2026 across 59 census tracts in Onondaga County: score 16 of 26, a population-to-provider ratio of 8,219:1 against a 3,000:1 goal, and a designation population of 74,537, of whom 27.9% are below the poverty line. A parallel Low-Income Population Mental Health HPSA, LI-City of Syracuse RSA 52, score 19, covers the same population, and two facility-based designations sit inside city limits, Syracuse Community Health Center Inc at 819 S Salina St (PC score 18, MH score 20, continuously designated since 2003) and Liberty Resources Inc at 1045 James St (PC score 20, MH score 16, designated 2023). A separate Medicaid-Eligible-Population geographic HPSA covering overlapping tracts was withdrawn 07/01/2026, so the Low-Income Population designation is the one currently in force 78.
A direct telehealth evaluation answers the specific thing Syracuse lacks: a published price and an appointment that does not depend on a referral or a drive out to DeWitt. The New York GLP-1 overview covers statewide rules.
Astra treats patients in New York through state-licensed physicians.
Local options
Slim Weight Loss Clinic (Syracuse location) — The only address of all providers checked that the Census Bureau geocoder confirms sits inside true Syracuse city limits (120 E Washington St, Suite 277, downtown; GEOID 3673000). Its own site publishes no semaglutide/tirzepatide price — visitors are routed only to a consultation-request form. Confirmed by direct site fetch: no dollar figure appears anywhere on the page. https://slimweightlossclinic.com/locations/syracuse-ny/(checked 2026-08-28)
Flawless Image Medical Aesthetics — Nearest clinic with a fully itemized, published GLP-1 price — but its address (5805 Bridge St) geocodes to the Village of East Syracuse, Town of DeWitt, confirmed outside city-of-Syracuse limits (Census county-subdivision GEOID 3606720478 / incorporated-place GEOID 3623052, not Syracuse's 3673000). Publishes GLP-1/GIP injectable pricing at $360/mo cash (or $385/mo by card) for months 1-3, rising to $360-$475/mo thereafter depending on dose; the page does not pair a specific 'semaglutide' dose figure with this price, so treat it as a general GLP-1/GIP rate, not a semaglutide-specific one. Free consultations and labs, month-to-month, no contract. https://www.flawlessimagemedspa.com/weightloss-injectables--phentermine.html(checked 2026-08-28)
Captivate IV Wellness & Beauty Bar — Address (4306 E Genesee St, carrying a 'Syracuse, NY 13214' postal designation) returns no incorporated-place match in the Census geocoder, indicating it sits in unincorporated DeWitt just outside the city line. Publishes a bundled 'SLIM' weight-loss membership starting at $175/month (provider check-ins, labs, body-composition scans, infrared sauna) rather than an itemized semaglutide/tirzepatide drug price. https://www.captivatewellness.com/treatments/weight-loss-injections/(checked 2026-08-28)
Frequently asked questions
What does semaglutide or tirzepatide cost in Syracuse, NY?
No clinic verified to sit inside Syracuse city limits publishes a semaglutide or tirzepatide price on its own site. The nearest published prices sit just outside the city line, in East Syracuse and DeWitt: GLP-1/GIP injectables starting around $360/mo cash for the first 3 months (rising to $360-$475/mo after), or a bundled weight-loss membership from $175/mo. Astra's price is the same in Syracuse as everywhere else Astra operates: $68/mo for semaglutide or $118/mo for tirzepatide, on 12-month plans ($816 / $1,416 billed annually).
Is Syracuse, NY a health professional shortage area (HPSA)?
Yes. HRSA's currently active Low-Income Population Primary Care HPSA covering Syracuse (re-designated 03/26/2026) shows a population-to-provider ratio of 8,219:1 against a 3,000:1 goal, across a designation population of 74,537 people, 27.9% of whom live below the poverty line. A parallel Mental Health HPSA covers the same population.
How does Syracuse's obesity rate compare to New York State overall?
Syracuse's adult obesity rate is 41.5% (crude prevalence, CDC PLACES, BRFSS 2023) versus 36.9% for Onondaga County and 28.0% for New York State overall (CDC BRFSS state survey, same year) — a 13.5-point city-to-state gap. The state figure uses a different survey methodology than the city/county small-area model, so treat the exact gap size as directional.
Does New York Medicaid cover Wegovy or Zepbound for weight loss in Syracuse?
No. NYRx, New York Medicaid's pharmacy program, excludes drugs prescribed for weight loss under Social Security Act §1927(d)(2), per the state's current pharmacy policy guidelines (March 2026). The same drugs remain covered when prescribed for type 2 diabetes. New York is not among the 13 states KFF identified as covering GLP-1s for obesity under Medicaid fee-for-service as of January 2026.
Is Astra cheaper in Syracuse?
There's no verified in-city price to compare against — no clinic confirmed inside Syracuse city limits publishes one. Against the nearest published local prices (just outside the city, in East Syracuse and DeWitt), which start around $175-$420/mo and can rise after an introductory period, Astra's flat $68/mo semaglutide or $118/mo tirzepatide is lower on a like-for-like monthly basis — but the honest comparison here is Astra's price transparency versus a local market where most nearby providers don't publish a price at all.